Allstate
ALL NYSE Property & Casualty Insurance Financials FY2016βFY2025
Allstate's revenue rose 5.6% to $67.7 billion in fiscal 2025. Its net margin was 15.2%, up from 7.3% a year earlier. Free cash flow was $9.9 billion, up 13.3%. It paid out $2.3 billion in dividends and buybacks, 23% of free cash flow. The diluted share count fell 0.3%.
What Allstate does
No business description yet.
- Legal name
- ALLSTATE CORP
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0000899051-26-000031
0000899051
Revenue and margins
Allstate had $67.7B of revenue in fiscal 2025, up 5.6% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 26.3% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $9.9B in fiscal 2025, 14.6% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Allstate returned $2.3B to shareholders in fiscal 2025, 23% of free cash flow. The diluted share count fell 0.3%.
Value Allstate yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$1.9B and divides by 267.1M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 5.1x Β· peers 11.0x Β· sector 13.7x.
Balance sheet
Cash, debt and the ratios that show how comfortably Allstate can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $4.8B | $4.9B | $5.9B | $5.2B | $5.6B |
| Debt incl. finance leases | $8.0B | $8.0B | $7.9B | $8.1B | $7.5B |
| Net debt / EBITDA | 0.7x | β | 2.8x | 0.4x | 0.1x |
| Debt / equity | 0.3x | 0.5x | 0.5x | 0.4x | 0.2x |
| Interest coverage | 9.8x | β4.3x | 0.1x | 15.6x | 34.3x |
| Total assets | $99.4B | $98.0B | $103.4B | $111.6B | $119.8B |
| Total liabilities | $74.3B | $80.6B | $85.7B | $90.3B | $89.2B |
| Shareholders' equity | $24.9B | $17.5B | $17.8B | $21.4B | $30.6B |
| Net debt (β = net cash) | $3.2B | $3.1B | $2.1B | $2.8B | $1.9B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$57.3M
7 insiders
Of sales under plans
50%
$28.7M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 11, 2026 | Mario RizzoChief Operating Officer-AIC | Sold | 56,225 | $264.48 | $14.9M | Form 4 |
| Aug 7, 2026 | John E DugenskePres, Invest. & Corp. Strategy | Sold | 32,996 | $269.33 | $8.9M | Form 4 |
| Jun 1, 2026 | Andrea RedmondDirector | Sold | 2,225 | $202.91 | $0.5M | Form 4 |
| May 22, 2026 | Mark Q PrindivilleFormer Section 16 officer | Sold | 1,550 | $216.27 | $0.3M | Form 4 |
| May 1, 2026 | Mario RizzoChief Operating Officer-AIC | Sold | 18,578 | $218.80 | $4.1M | Form 4 |
| Mar 16, 2026 | Thomas J WilsonChairman, President & CEO, Director | Sold plan | 16,807 | $208.90 | $3.5M | Form 4 |
| Mar 2, 2026 | Thomas J WilsonChairman, President & CEO, Director | Sold plan | 16,807 | $212.26 | $3.6M | Form 4 |
| Feb 25, 2026 | Jesse E MertenPresPersonalProperty-Liability | Sold plan | 33,986 | $208.57 | $7.1M | Form 4 |
| Feb 17, 2026 | Thomas J WilsonChairman, President & CEO, Director | Sold plan | 16,807 | $210.48 | $3.5M | Form 4 |
| Feb 2, 2026 | Thomas J WilsonChairman, President & CEO, Director | Sold plan | 16,807 | $200.71 | $3.4M | Form 4 |
| Jan 12, 2026 | Thomas J WilsonChairman, President & CEO, Director | Sold plan | 16,807 | $207.82 | $3.5M | Form 4 |
| Jan 7, 2026 | Suren GuptaPresident,Enterprise Solutions | Sold plan | 19,593 | $210.00 | $4.1M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | β / 9 | β / 9 | β / 9 |
| Accruals ratio | β4.4% | β4.0% | 0.2% |
| Altman Z'' | β | β | β |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Allstate ALL | $65.6B | 5.6% | β | 14.6% | 37.3% | 5.1x | β | |
| Chubb CB | $140.1B | 6.5% | β | β | 13.6% | 12.6x | β | Compare β |
| Progressive PGR | $133.2B | 16.3% | β | 19.6% | 39.2% | 11.4x | β | Compare β |
| Travelers Companies TRV | $83.9B | 5.2% | β | β | 20.1% | 10.5x | β | Compare β |
| Hartford HIG | $37.8B | 6.9% | β | 20.3% | 22.6% | 8.8x | β | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $37.4B | $39.4B | $39.8B | $41.5B | $41.9B | $50.6B | $51.4B | $57.1B | $64.1B | $67.7B |
| Interest expense | $295M | $335M | $332M | $327M | $318M | $330M | $335M | $379M | $395M | $395M |
| Pretax income | $2.8B | $4.5B | $2.6B | $6.0B | $6.9B | $2.9B | β$1.8B | β$348M | $5.8B | $13.2B |
| Income tax | $877M | $995M | $468M | $1.1B | $1.4B | $1.3B | β$488M | β$135M | $1.2B | $2.9B |
| Net income | $1.9B | $3.6B | $2.2B | $4.8B | $5.6B | $1.6B | β$1.3B | β$188M | $4.7B | $10.3B |
| Diluted EPS | $4.67 | $9.35 | $5.70 | $14.03 | $17.31 | $5.01 | β$5.14 | β$1.20 | $16.99 | $38.06 |
| Diluted shares | 0.38B | 0.37B | 0.35B | 0.33B | 0.32B | 0.30B | 0.27B | 0.26B | 0.27B | 0.27B |
| Cash flow | ||||||||||
| Cash from operations | $4.0B | $4.3B | $5.2B | $5.1B | $5.5B | $5.1B | $5.1B | $4.2B | $8.9B | $10.1B |
| Capital expenditure | $313M | $299M | $277M | $433M | $308M | $345M | $420M | $267M | $210M | $228M |
| Free cash flow | $3.7B | $4.0B | $4.9B | $4.7B | $5.2B | $4.8B | $4.7B | $4.0B | $8.7B | $9.9B |
| Depreciation and amortization | $382M | $483M | $511M | $647M | $686M | $1.1B | $847M | $704M | $555M | $482M |
| Stock-based compensation | $80.0M | $106M | $125M | $105M | $124M | $120M | $93.0M | $73.0M | $125M | $123M |
| Acquisitions | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Share buybacks | $1.3B | $1.5B | $2.3B | $1.7B | $1.7B | $3.1B | $2.5B | $335M | $2.0M | $1.2B |
| Dividends paid | $486M | $525M | $614M | $653M | $668M | $885M | $926M | $925M | $962M | $1.0B |
| Dividends and buybacks | $1.8B | $2.0B | $2.9B | $2.4B | $2.4B | $4.0B | $3.4B | $1.3B | $964M | $2.3B |
| Balance sheet | ||||||||||
| Cash and short-term investments | $4.7B | $2.6B | $3.5B | $4.5B | $8.1B | $4.8B | $4.9B | $5.9B | $5.2B | $5.6B |
| Total debt | $6.3B | $6.4B | $6.5B | $6.6B | $7.8B | $8.0B | $8.0B | $7.9B | $8.1B | $7.5B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Inventory | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Property and equipment, net | $1.1B | $1.1B | $1.0B | $1.1B | $1.1B | $939M | $987M | $859M | $669M | $627M |
| Total assets | $108.6B | $112.4B | $112.2B | $120.0B | $126.0B | $99.4B | $98.0B | $103.4B | $111.6B | $119.8B |
| Total liabilities | $88.0B | $89.9B | $90.9B | $94.0B | $95.8B | $74.3B | $80.6B | $85.7B | $90.3B | $89.2B |
| Shareholders' equity | $20.6B | $22.6B | $21.3B | $26.0B | $30.2B | $24.9B | $17.5B | $17.8B | $21.4B | $30.6B |
| Margins | ||||||||||
| EBITDA margin | 9.2% | 13.6% | 8.7% | 16.7% | 19.0% | 8.5% | β1.2% | 1.3% | 10.5% | 20.7% |
| Net margin | 5.0% | 9.0% | 5.4% | 11.7% | 13.3% | 3.2% | β2.5% | β0.3% | 7.3% | 15.2% |
| FCF margin | 9.8% | 10.2% | 12.3% | 11.3% | 12.4% | 9.4% | 9.1% | 6.9% | 13.6% | 14.6% |
| Returns | ||||||||||
| Return on capital | 9.3% | 15.7% | 9.6% | 19.5% | 42.4% | 13.1% | β4.7% | 0.1% | 22.4% | 37.3% |
| Return on equity | 9.3% | 16.5% | 9.9% | 20.5% | 19.8% | 5.9% | β6.1% | β1.1% | 23.8% | 39.5% |
| Return on assets | 1.8% | 3.2% | 1.9% | 4.2% | 4.5% | 1.4% | β1.3% | β0.2% | 4.3% | 8.9% |
| Growth | ||||||||||
| Revenue growth | 4.9% | 5.4% | 1.0% | 4.3% | 0.9% | 20.7% | 1.6% | 11.1% | 12.3% | 5.6% |
| Net income growth | β13.5% | 89.3% | β39.2% | 124.4% | 15.0% | β71.1% | β179.9% | β | β | 120.3% |
| EPS growth | β7.5% | 100.2% | β39.0% | 146.1% | 23.4% | β71.1% | β202.6% | β | β | 124.0% |
| FCF growth | 11.1% | 9.1% | 22.0% | β4.1% | 10.4% | β8.0% | β1.5% | β15.7% | 120.2% | 13.3% |
| Share count change | β7.3% | β2.5% | β4.0% | β5.6% | β5.4% | β5.2% | β9.3% | β3.2% | 2.0% | β0.3% |
| Financial health | ||||||||||
| Net debt / EBITDA | 0.5x | 0.7x | 0.9x | 0.3x | β0.0x | 0.7x | β | 2.8x | 0.4x | 0.1x |
| Debt / equity | 0.3x | 0.3x | 0.3x | 0.3x | 0.3x | 0.3x | 0.5x | 0.5x | 0.4x | 0.2x |
| Interest coverage | 10.3x | 14.6x | 8.9x | 19.2x | 22.9x | 9.8x | β4.3x | 0.1x | 15.6x | 34.3x |
| Capital allocation | ||||||||||
| Capex / revenue | 0.8% | 0.8% | 0.7% | 1.0% | 0.7% | 0.7% | 0.8% | 0.5% | 0.3% | 0.3% |
| Stock comp / revenue | 0.2% | 0.3% | 0.3% | 0.3% | 0.3% | 0.2% | 0.2% | 0.1% | 0.2% | 0.2% |
| Payouts / FCF | 49.5% | 50.3% | 59.6% | 50.9% | 46.4% | 83.9% | 73.3% | 31.8% | 11.1% | 23.0% |
| Quality scores | ||||||||||
| Accruals ratio | β2.0% | β0.7% | β2.7% | β0.2% | 0.1% | β3.1% | β6.5% | β4.4% | β4.0% | 0.2% |
Source: SEC EDGAR XBRL filings (CIK 0000899051). Data updated October 9, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.